The past 60 years in liver surgery

Tanabe, Kenneth K.

doi:10.1002/cncr.23652

Cited by 18 publications

(26 citation statements)

References 76 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…When the liver is imaged by CT with contrast in the portal venous phase, the different primary blood supply of healthy liver and metastases reduces contrast enhancement of metastases, rendering them more clearly apparent on scans. CT arterioportography became the study of choice in the 1980s and 1990s for the detection of liver metastases [4]. Continued improvements in CT scanner technology, including faster helical scanning and the development of multidetectors CT scanners, were critically important in sustaining the progress of liver surgery.…”

Section: Imagingmentioning

confidence: 99%

“…The first electrocautery device, the surgical Bovie knife, was developed commercially in 1928 by 2 Americans, Cushing and Bovie; to this day, electrocautery serves as the primary means of achieving haemostasis in the liver [4]. The use of ultrasound energy for dissection was introduced in 1984 by Hodgson and Delguerico as a way of disrupting hepatic parenchyma without The second significant concept at this time was that of adequate exposure, especially for trauma to the posterior superior segment of the liver.…”

Section: Technical Tools For Liver Transectionmentioning

confidence: 99%

“…The history of liver surgery in the literature is divided into three rather distinct periods; the first, from ancient times up to the late 1800s when the liver's anatomy was the main area of concern; the second, from 1880 through to World War II when surgical considerations were at the forefront; and the third, the last 40 years when with a few notable exceptions, surgical anatomy and anatomic surgery came to the fore [1,4,5].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The history of liver surgery, hepatectomy and haemostasis

2010

View full text Add to dashboard Cite

Liver surgery has advanced remarkably, but major challenges remain. These include developing more efficient minimally invasive surgical techniques, improving patient selection for any given treatment modality, and eliminating the risk of recurrence, particularly in the liver. The use of techniques involving virtual reality and robotic surgery is developing. More accurate methods of determining liver functional reserve and investigating liver regeneration are necessary. The application of gene therapy to the management of liver tumours is in its infancy. Finally, in the area of liver transplantation, a solution to tissue tolerance is close and the possibility of xenografts is on the horizon.

show abstract

Section: Imagingmentioning

confidence: 99%

Section: Technical Tools For Liver Transectionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The history of liver surgery, hepatectomy and haemostasis

2010

View full text Add to dashboard Cite

show abstract

“…Conservative management is recommended for BFLLs such as hepatic cavernous hemangiomas (HCHs) and focal nodular hyperplasias (FNHs) (2), and the use of surgical treatments should mainly be focused on patients with large lesions, symptoms associated with the nodule and lesions with malignant potential. Resection is a common method for treating a BFLL, however, a hepatectomy is a dangerous and complex procedure (3) and indications for the resection of a BFLL must be assessed cautiously (4). More recent non-surgical modalities, such as transcatheter arterial embolization (TAE) (5) and radiofrequency (RF) ablation (6,7), have provided safe, effective and minimally invasive treatments for BFLLs in selected patients.…”

Section: Introductionmentioning

confidence: 99%

Percutaneous microwave ablation for benign focal liver lesions: Initial clinical results

Cheng

Liang

et al. 2016

Oncology Letters

View full text Add to dashboard Cite

Abstract. Benign focal liver lesions (BFLLs) have become a common disease diagnosed in the clinical setting following the advancement of imaging techniques. The aim of the present study was to evaluate the safety and clinical outcomes of percutaneous microwave (MW) ablation, guided by ultrasound (US), for the treatment of BFLLs. Between May 2005 and January 2011, 44 BFLLs (mean maximum diameter, 33.9±13.1 mm) in 37 patients (23 women and 14 men) were treated by US-guided percutaneous MW ablation with cooled-shaft antennae. The pathological diagnosis of a BFLL was confirmed in 91.9% (34/37) of patients using a US-guided core needle biopsy prior to ablation. The BFLLs in the other 3 cases were diagnosed by typical presentations on contrast-enhanced imaging, as the patients refused to undergo biopsies. Five inclusion criteria, including indeterminate diagnoses of nodules on contrast-enhanced imaging prior to pathological verification, were recommended. The median follow-up period was 27.0 months (range, 6-73 months). The mean MW ablation energy and time were 55.0±41.6 kJ (range, 13.5-207 kJ) and 1,039.9±706.2 sec (range, 270-3,450 sec) per lesion, respectively. In total, 40 nodules (90.9%) were completely ablated, and no evidence of recurrence was demonstrated on contrast-enhanced imaging follow-up. The other 4 nodules (9.1%) were partially ablated due to the proximity of adjacent vital organs. Minor complications without sequelae included local pain and transient hemoglobinuria and no major complications occurred in peri-ablation. Overall, US-guided percutaneous MW ablation is a safe, effective and minimally invasive therapy for BFLLs in selected patients who are non-surgical candidates.

show abstract

“…Hepatectomy is a dangerous and complex operation [1][2][3][4][5][6] . The choice of surgical treatment for benign hepatic lesion is controversial.…”

Section: Introductionmentioning

confidence: 99%

Liver resection for benign hepatic lesions: A retrospective analysis of 827 consecutive cases

Feng¹,

Huang²,

Xu³

et al. 2008

WJG

View full text Add to dashboard Cite

AIM:To analyze the operative and perioperative factors associated with hepatectomy of benign hepatic lesions. METHODS: A total of 827 condecutive cases of benign hepatic lesion undergoing hepatectomy from January 1986 to December 2005 in the Chinese PLA General Hospital were investigated retrospectively according to their medical documentation. RESULTS: The effect of operative and perioperative factors on the outcome of patients were analyzed. Of the 827 cases undergoing hepatectomy for more than 3 liver segments accounted for 22.1%, 316 (38.21%) required transfusion of blood products during operation. The average operating time was 220.59 ± 109.13 min, the average hospital stay after operation was 13.55 ± 9.38 d. Child-Pugh A accounted for 98.13%. The postoperative complication rate was 13.54% and the in-hospital mortality rate was 0.24%. Multivariate analysis showed that operating time (P = 0.004, OR = 1.003) and albumin value (P = 0.040, OR = 0.938) were the independent predictors of morbidity and indicated that operating time, blood transfusion, complication rate, and LOS had a trend to decrease. CONCLUSION: Hepatectomy for benign hepatic lesions can be performed safely with a low morbidity and mortality, provided that it is carried out with optimized perioperative management and an innovative surgical technique.

show abstract

The past 60 years in liver surgery

Cited by 18 publications

References 76 publications

The history of liver surgery, hepatectomy and haemostasis

The history of liver surgery, hepatectomy and haemostasis

Percutaneous microwave ablation for benign focal liver lesions: Initial clinical results

Liver resection for benign hepatic lesions: A retrospective analysis of 827 consecutive cases

Contact Info

Product

Resources

About